Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002985505 | SCV003292483 | pathogenic | not provided | 2022-01-07 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with GFM1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ile102Tyrfs*16) in the GFM1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GFM1 are known to be pathogenic (PMID: 16632485, 17160893). |
Baylor Genetics | RCV004572498 | SCV005058973 | likely pathogenic | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 | 2024-01-03 | criteria provided, single submitter | clinical testing |